Asunto(s)
Muerte , Relaciones Médico-Paciente , Médicos/psicología , Anécdotas como Asunto , HumanosRESUMEN
Angiodysplasia of the stomach, the proximal part of the small intestine, or both was diagnosed in 30 patients by upper gastrointestinal (Gl) endoscopy over a 40-month period. This diagnosis represented 4% of 676 patients referred over the same time period for endoscopic examination of suspected upper Gl bleeding. Twenty-three patients (77%) had experienced at least one episode of overt bleeding (hematemesis or melena) prior to diagnosis. Multiple gastroduodenal angiodysplastic lesions were found in 19 (63%) of the patients, and additional colonic angiodysplasia was detected in six of 12 patients who also underwent colonoscopy. Renal insufficiency was significantly more prevalent in the patients with angiodysplasia than in a comparison group of similar age with upper Gl bleeding from other lesions (60% v 24%). We conclude that angiodysplasia, although uncommon, should be considered in the differential diagnosis of both occult and overt upper Gl bleeding. The lesion appears to be associated with renal insufficiency.
Asunto(s)
Hemorragia Gastrointestinal/etiología , Enfermedades Vasculares/complicaciones , Adulto , Anciano , Enfermedades del Colon/complicaciones , Diagnóstico Diferencial , Enfermedades Duodenales/complicaciones , Femenino , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/patología , Gastroscopía , Humanos , Fallo Renal Crónico/complicaciones , Masculino , Persona de Mediana Edad , Estómago/irrigación sanguínea , Enfermedades Vasculares/diagnóstico , Enfermedades Vasculares/patologíaRESUMEN
We studied the relative prophylactic efficacies of recently derived immune globulin containing antibody to hepatitis B surface antigen (anti-HBs) and hepatitis B immune globulin in 60 intimate contacts exposed to acute type B hepatitis. Forty susceptible contacts were randomly assigned to treatment with either a single intramuscular dose of immune globulin or hepatitis B immune globulin (0.06 mL/kg of body weight), following which observation was maintained over a 12-month period. Twenty additional contacts received the equivalent of twice the dose of immune globulin given to the first group, and follow-up was maintained for six months. Neither the hepatitis B virus (HBV) attack rates (11% to 19%) nor the frequency of clinical illness (0% to 4.8%) was substantially different in the three groups. When compared with average frequencies reported in the literature, significantly lower illness rates were noted for immune globulin recipients. These data indicate that currently derived immune globulin as well as hepatitis B immune globulin may confer protection from illness (le, passive-active immunity) in the setting of intimate exposure to HBV.
Asunto(s)
Anticuerpos contra la Hepatitis B/inmunología , Antígenos de Superficie de la Hepatitis B/inmunología , Hepatitis B/prevención & control , Inmunización Pasiva , Inmunoglobulinas/inmunología , Enfermedad Aguda , Adolescente , Adulto , Ensayos Clínicos como Asunto , Femenino , Estudios de Seguimiento , Hepatitis B/inmunología , Hepatitis B/transmisión , Antígenos del Núcleo de la Hepatitis B/inmunología , Humanos , Masculino , Estudios Prospectivos , Distribución Aleatoria , Conducta Sexual , Factores de TiempoRESUMEN
A 78-year-old man with amyloidosis involving the esophagus is described. The clinical and radiographic features resembled classic achalasia, while esophageal manometrics demonstrated aperistalsis, incomplete LES relaxation, but a normal LES resting pressure. A review of the literature suggests that esophageal amyloid may have variable presentations. This patient was successfully managed with forceful pneumatic bag dilatation.